COVID-19 IgM/IgG Antibody Rapid Test
The COVID-19 IgM/IgG Antibody Rapid Test is a on-site rapid test that detects antibodies produced when infected by the COVID-19 virus (Corona Virus Disease), caused by 2019-nCoV (SARS-CoV-2).
The COVID-19 Rapid Test compliments existing nucleic acid / antigen detection (nasopharyngeal swab, sputum or alveolar lavage fluid specimen). These nucleic acid / antigen swab tests, which detects the virus, are currently not available due to government demand. The COVID-19 Rapid Test detects at the onset of symptoms, once a patient begins producing antibodies to fight the virus. For workplace and non-public applications, this qualitative screen can immensely assist in the assessment of individuals potentially showing flu, cold, or COVID-19 symptoms.
Rapid Results in
Make decisions based
on reliable results
How It Works
The COVID-19 Rapid Test is a simple point-of-care lateral flow immunoassay detecting IgM and IgG antibodies simultaneously against the COVID-19 virus in human blood within 15 minutes detecting patients at different infection stages. It does not detect the COVID-19 virus itself, but the antibodies produced to fight the virus.
It is widely accepted that IgM provides the first line of defense during viral infections, followed by the generation of adaptive, high affinity IgG responses for long-term immunity and immunological memory. Therefore, testing of COVID-19 IgM and IgG antibodies is an effective method for the rapid diagnosis of COVID-19 infection. Furthermore, detection of COVID-19 IgM antibodies tends to indicate a recent exposure to COVID-19, whereas detection of COVID-19 IgG antibodies indicates a later stage of infection. Thus, this combined antibody test could also provide information on the stage of infection.
Quickly screen then QUARANTINE!
The COVID-19 Antibody Rapid test will detect antibodies 5 to 7 days after symptoms first appear
The test will show clear results in 15 minutes, unlike a PCR test, which can take hours
The COVID-19 Antibody Rapid Test is cost effective, at approx. 5% of the cost of a PCR test
The test is easy to administer and perform by health personnel with no specific medical training
4 Easy Steps:
Diagnosis of COVID-19
At different stages of COVID-19 disease progression, the efficiency of nucleic acid and antibody detection is not the same. The two are used in synergy to complement each other, improve diagnosis and monitor disease progression.
Each box of COVD-19 rapid test kits contains everything you need to administer 20 tests, where you need them.
The full kit includes:
2. Test Devices
3. Alcohol Pad
5. Buffer solution
SARS-COV-2 Antigen and IgM/IgG Antibody Test Results and Clinical Significance
NOTICE for Canadian Organizations:
COVID-19 IgM/IgG Antibody Rapid Test Kits are not authorized for use in Canada at this time.
COVID-19 Rapid Test is in the process of Health Canada licensing. We are monitoring the Health Canada licensing process daily and anticipate the COVID-19 Rapid Test to be issued a Class III medical device license in the very near future (days or weeks).
The status of the Health Canada application can be found at: https://www.canada.ca/en/health-canada/services/drugs-health-products/medical-devices/covid-19.html
ModoHR is working closely with our partner, and will only finalize sale or ship COVID-19 Rapid Test Kits in Canada upon Health Canada licensing. The COVID-19 Rapid Test Kit is currently licensed for use in the US by the FDA, certified in Europe (CE), and is being sold and used worldwide.
In the meantime, ModoHR will continue to take reservations for our COVID-19 Rapid Test Kits in Canada, as the timeline to manufacture and receive test kits in Canada is significantly growing due to high global demand. There will be a full refund if a Health Canada license is not issued.
Complete the form below and a respresentative will be in touch shortly.
Due to the elevated demand for COVID-19 IgM/IgG Antibody Rapid Tests, orders will be taken on a first come first serve basis. All orders must be pre-paid before shipment.